Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 310 460 | déclaré | 31 déc. 2025 | tx 545+12 999 702−12 052 985 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 31 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28 570 | 0.00 USD | |
| 31 déc. 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 28 570 | 772.09 USD | |
| 31 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28 570 | 0.00 USD | deriv |
| 09 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 146 815 | 555.67 USD | |
| 09 déc. 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 131 874 | 701.51 USD | |
| 09 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 146 815 | 0.00 USD | deriv |
| 10 juin 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 37 900 | 0.00 USD | |
| 10 juin 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 75 799 | 0.00 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 3 387 | 968.43 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 373 | 988.36 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 182 | 987.38 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 442 | 986.40 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 647 | 985.62 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 53 | 984.02 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 727 | 983.88 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 303 | 982.29 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2 283 | 981.52 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 223 | 980.72 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 504 | 979.87 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 4 865 | 978.44 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 9 851 | 977.42 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 6 885 | 976.56 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 111 | 965.69 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 782 | 966.29 USD | |
| 15 mai 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 428 | 967.45 USD |